Further to information released on April 9 and April 30, today’s focus is on further concerns and promising solutions.  The Drug Safety & Effectiveness Network (DSEN) report of 2012 confirms concerns about the strong association between common stomach medications and C. difficile infections (CDI). “If the regulator cannot or will not act in the public […]

In 2005, I was assured by the Health Minister of the day that Health Canada was actively investigating C. difficile deaths in Canadian hospitals and the relation to stomach acid suppressant drugs called Proton Pump Inhibitors (PPIs).   A study by the Canadian Nosocomial Infection Surveillance Program (CNISP) would get to the bottom of it.  It […]